TI
FRTX

Telemetry Investments’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Telemetry Investments’s Portfolio FRTX Stock Details FRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$95K Sell
65,000
-1,000
-2% -$1.77K 0.22% 89
2022
Q3 		$118K Buy
66,000
+41,889
+174% +$121K 0.19% 114
2022
Q2 		$137K Sell
24,111
-18,225
-43% -$165K 0.21% 116
2022
Q1 		$510K Sell
42,336
-13,952
-25% -$151K 0.82% 47
2021
Q4 		$580K Buy
56,288
+40,747
+262% +$732K 0.76% 44
2021
Q3 		$504K Buy
15,541
+1,986
+15% +$64.4K 0.69% 48
2021
Q2 		$580K Buy
13,555
+2,159
+19% +$88.8K 0.81% 48
2021
Q1 		$559K Buy
11,396
+7,043
+162% +$387K 0.63% 61
2020
Q4 		$153K Buy
+4,353
New +$137K 0.28% 86

Other funds holding FRTX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $849M AUM 470.8% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $501B AUM 22.01% 1-Year Est. Return